Xintela AB (publ) announced that the company has recruited Liselotte Theorell as Director Product Development and Quality Management. Liselotte Theorell has broad experience of drug development, production and quality management, and has been responsible for the establishment of quality management systems for GMP, GLP (Good Laboratory Practice) and GCP (Good Clinical Practice) ­ in companies such as Cellaviva AB, SentoClone AB, Biovitrum AB and Moberg Pharma AB. Initially, Liselotte Theorell will focus on establishing procedures for GMP production of Xintela's stem cells for upcoming clinical studies.